MORRISVILLE, N.C.--(BUSINESS WIRE)--Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the availability of the new MFL-3000 prescription drug identification platform for law enforcement applications. The MFL-3000 analyzes prescription pills and other controlled substances via a Raman Spectroscopy hardware/software system and provides rapid identification of seized evidence. The platform includes Centice’s core RECAP™ technology which captures drug spectra for matching to a database of over 3,500 prescription drugs and an easy to use, Windows-based software application for collecting, organizing, communicating and managing spectra databases.
